{"id":22375,"date":"2023-07-18T08:13:12","date_gmt":"2023-07-18T02:43:12","guid":{"rendered":"https:\/\/johnsonfrancis.org\/general\/?p=22375"},"modified":"2023-07-18T09:16:05","modified_gmt":"2023-07-18T03:46:05","slug":"pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart","status":"publish","type":"post","link":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/","title":{"rendered":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart"},"content":{"rendered":"<p><iframe loading=\"lazy\" width=\"560\" height=\"315\" src=\"https:\/\/www.youtube.com\/embed\/GlCUF9VhlFs\" title=\"YouTube video player\" frameborder=\"0\" allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" allowfullscreen=\"\"><\/iframe><\/p>\n<h2><span style=\"color: #008000;\">Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart<\/span><\/h2>\n<p>Doxorubicin, also known as adriamycin is an effective drug against various types of cancers. But an important adverse effect of adriamcyin is that it can weaken the heart muscle if a certain dose is exceeded, in some individuals. A special formulation in which the medication is encapsulated within two layers known as liposome, is useful in reducing this toxicity. PEG or polyethylene glycol polymer is used to form these liposomes. Liposome covered adriamycin remains in blood five times more than the usual medication. Because of bigger size, its entry into normal blood vessels of the heart is reduced. At the same time it can enter the abnormal blood vessels of the tumour and destroy the tumour cells. Hence pegylated liposomal doxorubicin has better effect against the tumor and lesser side effects on the heart.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart Doxorubicin, also known as adriamycin is an effective drug against various types of cancers. But an important adverse effect of adriamcyin is that it can weaken the heart muscle if a certain dose is exceeded, in some individuals. A special formulation in which the [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":22377,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"nf_dc_page":"","footnotes":""},"categories":[7],"tags":[],"class_list":["post-22375","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels\" \/>\n<meta property=\"og:description\" content=\"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart Doxorubicin, also known as adriamycin is an effective drug against various types of cancers. But an important adverse effect of adriamcyin is that it can weaken the heart muscle if a certain dose is exceeded, in some individuals. A special formulation in which the [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/\" \/>\n<meta property=\"og:site_name\" content=\"All About Heart And Blood Vessels\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-18T02:43:12+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2023-07-18T03:46:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"895\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Johnson Francis\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Johnson Francis\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/\"},\"author\":{\"name\":\"Johnson Francis\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\"},\"headline\":\"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart\",\"datePublished\":\"2023-07-18T02:43:12+00:00\",\"dateModified\":\"2023-07-18T03:46:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/\"},\"wordCount\":156,\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg\",\"articleSection\":[\"General\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/\",\"name\":\"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg\",\"datePublished\":\"2023-07-18T02:43:12+00:00\",\"dateModified\":\"2023-07-18T03:46:05+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#primaryimage\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg\",\"contentUrl\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg\",\"width\":1200,\"height\":895},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#website\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/\",\"name\":\"All About Heart And Blood Vessels\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/#\\\/schema\\\/person\\\/f35ea33ecf9c9923597de2691ebed1a7\",\"name\":\"Johnson Francis\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g\",\"caption\":\"Johnson Francis\"},\"description\":\"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal\",\"url\":\"https:\\\/\\\/johnsonfrancis.org\\\/general\\\/author\\\/jf\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/","og_locale":"en_US","og_type":"article","og_title":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels","og_description":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart Doxorubicin, also known as adriamycin is an effective drug against various types of cancers. But an important adverse effect of adriamcyin is that it can weaken the heart muscle if a certain dose is exceeded, in some individuals. A special formulation in which the [&hellip;]","og_url":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/","og_site_name":"All About Heart And Blood Vessels","article_published_time":"2023-07-18T02:43:12+00:00","article_modified_time":"2023-07-18T03:46:05+00:00","og_image":[{"width":1200,"height":895,"url":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg","type":"image\/jpeg"}],"author":"Johnson Francis","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Johnson Francis","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#article","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/"},"author":{"name":"Johnson Francis","@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7"},"headline":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart","datePublished":"2023-07-18T02:43:12+00:00","dateModified":"2023-07-18T03:46:05+00:00","mainEntityOfPage":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/"},"wordCount":156,"image":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg","articleSection":["General"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/","url":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/","name":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart - All About Heart And Blood Vessels","isPartOf":{"@id":"https:\/\/johnsonfrancis.org\/general\/#website"},"primaryImageOfPage":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#primaryimage"},"image":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#primaryimage"},"thumbnailUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg","datePublished":"2023-07-18T02:43:12+00:00","dateModified":"2023-07-18T03:46:05+00:00","author":{"@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7"},"breadcrumb":{"@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#primaryimage","url":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg","contentUrl":"https:\/\/johnsonfrancis.org\/general\/wp-content\/uploads\/2023\/07\/Pegylated-Liposomal-Doxorubicin-Special-Formulation-to-Reduce-Toxicity-to-the-Heart.jpg","width":1200,"height":895},{"@type":"BreadcrumbList","@id":"https:\/\/johnsonfrancis.org\/general\/pegylated-liposomal-doxorubicin-special-formulation-to-reduce-toxicity-to-the-heart\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/johnsonfrancis.org\/general\/"},{"@type":"ListItem","position":2,"name":"Pegylated Liposomal Doxorubicin: Special Formulation to Reduce Toxicity to the Heart"}]},{"@type":"WebSite","@id":"https:\/\/johnsonfrancis.org\/general\/#website","url":"https:\/\/johnsonfrancis.org\/general\/","name":"All About Heart And Blood Vessels","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/johnsonfrancis.org\/general\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/johnsonfrancis.org\/general\/#\/schema\/person\/f35ea33ecf9c9923597de2691ebed1a7","name":"Johnson Francis","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/80861b82c3f559be9e413245c5643b6c483c93495507facfe32cf96ccd8bcffd?s=96&d=mm&r=g","caption":"Johnson Francis"},"description":"Former Professor of Cardiology, Calicut Govt. Medical Kozhikode, Kerala, India. Editor-in-Chief, BMH Medical Journal","url":"https:\/\/johnsonfrancis.org\/general\/author\/jf\/"}]}},"amp_enabled":true,"_links":{"self":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/22375","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/comments?post=22375"}],"version-history":[{"count":2,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/22375\/revisions"}],"predecessor-version":[{"id":22378,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/posts\/22375\/revisions\/22378"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/media\/22377"}],"wp:attachment":[{"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/media?parent=22375"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/categories?post=22375"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/johnsonfrancis.org\/general\/wp-json\/wp\/v2\/tags?post=22375"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}